This “Invasive Candidiasis Market Insights, Epidemiology, and Market Forecast - 2032” report delivers an in-depth understanding of the Invasive Candidiasis, historical and forecasted epidemiology as well as the Invasive Candidiasis market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
The Invasive Candidiasis market report provides current treatment practices, emerging drugs, the Invasive Candidiasis market share of the individual therapies, and current and forecasted Invasive Candidiasis market size from 2019 to 2032, segmented by the seven major markets. The report also covers current Invasive Candidiasis treatment practices/algorithms and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Candida is a type of yeast that is normally found in the gastrointestinal (GI) tract and on people's skin. In individuals with certain underlying conditions, Candida can cause a serious infection called Invasive Candidiasis. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” Invasive Candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body.
Most cases of Invasive Candidiasis are health care-associated infections (HAIs). People who are at high risk for developing Invasive Candidiasis include those who: are admitted in the ICU, have a weakened immune system, have recently had surgery, have recently received lots of antibiotics in the hospital, have kidney failure, or are on hemodialysis, have diabetes and are pre-term babies.
People who develop Invasive Candidiasis are often already sick from other medical conditions, so it can be difficult to know which symptoms are related to a Candida infection. However, the most common symptoms of Invasive Candidiasis are fever and chills that do not improve after antibiotic treatment for suspected bacterial infections. Other symptoms can develop if the infection spreads to other parts of the body, such as the heart, brain, eyes, bones, or joints.
Invasive Candidiasis does not spread directly from person to person. However, some species of the fungus that causes Invasive Candidiasis normally live on the skin, so it is possible that Candida can be passed from one person to another and possibly cause an infection in someone who is at high risk.
The Invasive Candidiasis epidemiology covered in the report provides historical as well as forecasted Invasive Candidiasis epidemiology [segmented as Total Incident Cases of Invasive Candidiasis, Age-specific Cases of Invasive Candidiasis, Type-specific Cases of Invasive Candidiasis, and Treated Cases of Invasive Candidiasis] in the 7MM covering the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan from 2019 to 2032.
Emerging Invasive Candidiasis drugs
The report details the emerging Invasive Candidiasis therapies under the late and mid-stage of development for Invasive Candidiasis treatment.
This segment gives a thorough detail of the Invasive Candidiasis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need for the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to the publisher, the Invasive Candidiasis market in the 7MM is expected to witness a major change in the study period 2019-2032.
This will help in understanding the Invasive Candidiasis drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in the market uptake and in making financial and regulatory decisions.
The Invasive Candidiasis market report provides current treatment practices, emerging drugs, the Invasive Candidiasis market share of the individual therapies, and current and forecasted Invasive Candidiasis market size from 2019 to 2032, segmented by the seven major markets. The report also covers current Invasive Candidiasis treatment practices/algorithms and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Geography Covered
- The United States
- EU4 (Germany, France, Italy, and Spain) and the United Kingdom
- Japan
Invasive Candidiasis Understanding and Treatment Algorithm
This Invasive Candidiasis market report gives a thorough understanding of Invasive Candidiasis by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis, and treatment.Candida is a type of yeast that is normally found in the gastrointestinal (GI) tract and on people's skin. In individuals with certain underlying conditions, Candida can cause a serious infection called Invasive Candidiasis. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” Invasive Candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body.
Most cases of Invasive Candidiasis are health care-associated infections (HAIs). People who are at high risk for developing Invasive Candidiasis include those who: are admitted in the ICU, have a weakened immune system, have recently had surgery, have recently received lots of antibiotics in the hospital, have kidney failure, or are on hemodialysis, have diabetes and are pre-term babies.
People who develop Invasive Candidiasis are often already sick from other medical conditions, so it can be difficult to know which symptoms are related to a Candida infection. However, the most common symptoms of Invasive Candidiasis are fever and chills that do not improve after antibiotic treatment for suspected bacterial infections. Other symptoms can develop if the infection spreads to other parts of the body, such as the heart, brain, eyes, bones, or joints.
Invasive Candidiasis does not spread directly from person to person. However, some species of the fungus that causes Invasive Candidiasis normally live on the skin, so it is possible that Candida can be passed from one person to another and possibly cause an infection in someone who is at high risk.
Invasive Candidiasis Diagnosis
Diagnosis of Invasive Candidiasis relays on medical history, symptoms, physical examinations, and laboratory tests. The most common test for Invasive Candidiasis is a blood culture test in which a blood sample or sample from the infected body site is collected and assessed for the growth of Candida in the procured blood specimen. Development of PCR assays and other new modalities paves the opportunity to shorten the time to an accurate diagnosis, and earlier treatment initiation.Invasive Candidiasis Treatment
The specific type and dose of antifungal medication used to treat Invasive Candidiasis usually depend on the patient's age, immune status, and location and severity of the infection. For most adults, the initial recommended antifungal treatment is an echinocandin (caspofungin, micafungin, or anidulafungin) given through the vein (intravenous). The echinocandins are cyclic lipopeptides that inhibit the transmembrane glucan synthase complex (Fks1), a biosynthetic enzyme that produces 1, 3-β-d-glucan, the major fungal cell-wall carbohydrate. Disruption of 1, 3-β-d-glucan synthesis damages cellular integrity and leads eventually to cell rupture and death. Fluconazole, amphotericin B, and other antifungal medications June also be appropriate in certain situations.Invasive Candidiasis Epidemiology
The Invasive Candidiasis epidemiology section provides insights into the historical and current Invasive Candidiasis patient pool and forecasted trends for the seven individual major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Invasive Candidiasis report also provides the incident patient pool, its trends, and assumptions undertaken.Key Findings
According to a study by CDC (2023), Candidemia is one of the most common bloodstream infections in the United States. During 2013-2017, the average incidence (rate of new infections) was approximately 9 per 100,000 people; however, this number varies substantially by geographic location and patient population. CDC estimated that approximately 25,000 cases of Candidemia occur nationwide each year. Though it is the most common form of Invasive Candidiasis, Candidemia does not represent all forms of Invasive Candidiasis. The infection can also occur in the heart, kidney, bones, and other internal organs without being detected in the blood. The number of cases of Invasive Candidiasis might be twice as high as the estimate for Candidemia.The Invasive Candidiasis epidemiology covered in the report provides historical as well as forecasted Invasive Candidiasis epidemiology [segmented as Total Incident Cases of Invasive Candidiasis, Age-specific Cases of Invasive Candidiasis, Type-specific Cases of Invasive Candidiasis, and Treated Cases of Invasive Candidiasis] in the 7MM covering the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan from 2019 to 2032.
Country-wise Invasive Candidiasis Epidemiology
The epidemiology segment also provides the Invasive Candidiasis epidemiology data and findings across the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.Invasive Candidiasis Drug Chapters
The drug chapter segment of the Invasive Candidiasis report encloses a detailed analysis of Invasive Candidiasis marketed drugs and late-stage (Phase III and Phase II) Invasive Candidiasis pipeline drugs. It also helps understand the Invasive Candidiasis clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug, and the latest news and press releases.Emerging Invasive Candidiasis drugs
The report details the emerging Invasive Candidiasis therapies under the late and mid-stage of development for Invasive Candidiasis treatment.
Invasive Candidiasis Market Outlook
The Invasive Candidiasis market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Invasive Candidiasis market trends by analyzing the impact of current therapies on the market, unmet needs, and demand for better technology.This segment gives a thorough detail of the Invasive Candidiasis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need for the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to the publisher, the Invasive Candidiasis market in the 7MM is expected to witness a major change in the study period 2019-2032.
Key Findings
This section includes a glimpse of the Invasive Candidiasis market in the 7MM.The United States: Invasive Candidiasis Market Outlook
This section provides the total Invasive Candidiasis market size and market size by therapies in the United States.EU4 and the United Kingdom: Invasive Candidiasis Market Outlook
The total Invasive Candidiasis market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom are provided in this section.Japan: Invasive Candidiasis Market Outlook
The total Invasive Candidiasis market size and market size by therapies in Japan are also mentioned.Invasive Candidiasis Drug Uptake
This section focuses on the rate of uptake of the potential drugs recently launched in the Invasive Candidiasis market or expected to get launched in the market during the study period 2019-2032. The analysis covers the Invasive Candidiasis market uptake by drugs, patient uptake by therapies, and sales of each drug.This will help in understanding the Invasive Candidiasis drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in the market uptake and in making financial and regulatory decisions.
Invasive Candidiasis Pipeline Development Activities
The report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Invasive Candidiasis's key players involved in developing targeted therapeutics.Invasive Candidiasis market clinical trial development activities
The report covers detailed information on collaborations, acquisitions, and mergers, licensing patent details, and other information on Invasive Candidiasis emerging therapies.Invasive Candidiasis Reimbursement Scenario
Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we consider reimbursement to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.KOL Views
To keep up with current epidemiology and market trends, we take KOLs and SMEs' opinions working on the Invasive Candidiasis domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies and treatment patterns along with Invasive Candidiasis market trends. This will support the clients in potential upcoming novel treatments by identifying the overall scenario of the market and the unmet needs.Competitive Intelligence Analysis
The publisher performs competitive and market intelligence analysis of the Invasive Candidiasis market by using various competitive intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies, etc. The inclusion of the analysis entirely depends upon the data availability.Scope of the Report
- Descriptive overview of Invasive Candidiasis, disease overview, patient journeys, treatment algorithms, diagnosis, and currently available therapies
- Comprehensive insight into the Invasive Candidiasis epidemiology and forecasts in the 7MM
- An all-inclusive account of both the current and emerging therapies for Invasive Candidiasis, along with the assessment of new therapies, expected to have an impact on the current treatment landscape
- Exhaustive analysis of the Invasive Candidiasis market; historical and forecasted covering drug outreach in the 7MM
- Detailed patient-based market forecasting determines the trends shaping and driving the global Invasive Candidiasis market
Report Highlights
- In the coming years, the Invasive Candidiasis market is set to change due to the rising awareness of the disease and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
- The companies and academics are working to assess challenges and seek opportunities that could influence Invasive Candidiasis R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
- Major players are involved in developing Invasive Candidiasis therapies. The launch of emerging therapies will significantly impact the Invasive Candidiasis market
- A better understanding of Invasive Candidiasis pathogenesis will also contribute to the development of novel therapeutics for Invasive Candidiasis
- This in-depth analysis of the Invasive Candidiasis pipeline assets across different stages of development (Phase III and Phase II), emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities
Invasive Candidiasis Report Insights
- Patient-Based Market Forecasting
- Therapeutic approaches
- Invasive Candidiasis pipeline analysis
- Invasive Candidiasis market size and trends
- Invasive Candidiasis market opportunities
- Impact of upcoming therapies
Invasive Candidiasis Report Key Strengths
- 10 years forecast
- The 7MM Coverage
- Invasive Candidiasis epidemiology segmentation
- Key cross competition
- KOL views
- Invasive Candidiasis drugs uptake
Invasive Candidiasis Report Assessment
- Current treatment practices
- Unmet needs
- Invasive Candidiasis pipeline product profiles
- Invasive Candidiasis market attractiveness
Key Questions Answered
Invasive Candidiasis market insights:
- What would be the Invasive Candidiasis market growth till 2032, and what will be the resultant market size in 2032?
- What was the Invasive Candidiasis drug class share (in percentage) distribution in 2019, and how would it look in 2032?
- What would be the Invasive Candidiasis total market size and market size by therapies across the 7MM during the forecast period (2022-2032)?
- What are the key findings of the market across the 7MM, and which country will have the largest Invasive Candidiasis market size during the forecast period (2022-2032)?
- How would the unmet needs affect the Invasive Candidiasis market dynamics and subsequent analysis of the associated trends?
Invasive Candidiasis Epidemiology Insights:
- What are the disease risk, burden, and regional/ethnic differences of Invasive Candidiasis?
- What is the historical and forecasted Invasive Candidiasis patient pool in the 7MM, and where can one observe the highest patient population and growth opportunities?
- What are the key factors driving the epidemiology trends for the seven major markets covering the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan?
Current Treatment Scenario, Marketed Drugs, and Emerging Therapies
- What are the current treatment guidelines and treatment options, in addition to approved therapies for Invasive Candidiasis in the United States, Europe, and Japan?
- What are the key collaborations (Industry-Industry, Industry-Academia), mergers and acquisitions, and licensing activities related to Invasive Candidiasis therapies?
- What are the recent novel therapies, targets, mechanisms of action, and technologies being developed to overcome the limitation of existing therapies?
- What are the clinical studies going on for Invasive Candidiasis and its status, along with the challenges faced?
Reasons to Buy
- The patient-based market forecast analysis will help in developing business strategies by understanding trends shaping and driving the Invasive Candidiasis market
- Organize sales and marketing efforts by identifying the best opportunities for Invasive Candidiasis in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan
- Identification of strong upcoming players in the market that will help devise strategies that will help in getting ahead of competitors
Table of Contents
1. Key Insights2. Executive Summary of Invasive Candidiasis3. Competitive Intelligence Analysis for Invasive Candidiasis6. Patient Journey9. Invasive Candidiasis Unmet Needs10. Key Endpoints of Invasive Candidiasis Treatment14. Attribute analysis16. Access and Reimbursement Overview of Invasive Candidiasis17. KOL Views18. Market Drivers19. Market Barriers21. Publisher Capabilities22. Disclaimer
4. Invasive Candidiasis: Market Overview at a Glance
5. Invasive Candidiasis: Disease Background and Overview
7. Invasive Candidiasis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
11. Invasive Candidiasis Marketed Products
12. Invasive Candidiasis Emerging Therapies
13. Invasive Candidiasis: Seven Major Market Analysis
15. 7MM: Market Outlook
20. Appendix
23. About the Publisher
List of Tables
List of Figures
